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INTRODUCTION
The Acquired Immunodeficiency Syndrome (AIDS) is due 
to infection by the Human Immune-deficiency Viruses 
(HIV). The infections cause progressive destruction of  
the Cell Mediated Immune (CMI) system, primarily by 
eliminating CD4+ T-helper lymphocytes. Opportunistic 
infections and tumors follow causing a progressive damage 
of  the body’s immune system.1,2
The damage done to the immune system results in 
immunological and haematological complications causing a 
number of  opportunistic infections (OIs). Haematological 
complications have been documented to be the second most 
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Background: Immunosuppressive Acidic protein (IAP) is a marker of the extent of 
immune defects occurring in most cancers. Its correlation with CD4 cell count used as an 
indicator of immune function and disease progression in Human Immuno-deficiency Virus 
(HIV) infection is not well documented. Aims and Objectives: To determine if IAP levels 
correlates with immunosupression and haematopathology occurring in HIV/AIDS infection. 
Materials and Methods: This cross sectional study was conducted at the Federal Teaching 
Hospital, Ido-Ekiti. One hundred and five participants consisting of 85 HIV infected test 
subjects and 20 control subjects were enrolled into the study. CD4 counts was obtained 
using SL Cyflow machine, IAP levels determined using ELISA kit for human IAP and Full 
blood count for all participants was obtained using Sysmex KX-21N Haematology Analyzer. 
Regression and correlation analysis was done on data using SPSS 28. Results: IAP showed 
a negative correlation with CD4 count (r= -0.6), (r= -0.9) and (r= -0.2) in the ART, NART 
and control groups. The pattern of the results was similar with other parameters except in 
Neutrophils (r= 0.2) (r= 0.3) and (0.1), Eosinophil (r= 0.6) (r= -0.4) and (r= -0.2) and 
Lymphocyte (r = -0.3) (r= -0.02) and (r= 0.05) in the ART, NART and control groups 
respectively. Conclusion: The outcome of this study show that a strong negative relationship 
exist between IAP and other immunohaematological parameters used for monitoring Immune 
status in HIV infection; however the information gotten is not sufficient to indicate IAP as a 
predictor of immune status in HIV infection. Further studies are therefore required to better 
elucidate the mechanism of increased IAP levels at different clinical stages of HIV infection.
Key words: Immunosuppressive acidic protein, CD4, HIV/AIDS, Immunosuppression, 
Haematopathology
Access this article online
Website: 
http://nepjol.info/index.php/AJMS
DOI: 10.3126/ajms.v8i5.17323 
E-ISSN: 2091-0576 
P-ISSN: 2467-9100
Address for correspondence: 
Dr. Olayanju A O, Senior Lecturer, Department of Medical Laboratory Science, College of Medicine and Health Sciences, AfeBabalola 
University, PMB 5454, Ado‑Ekiti, Ekiti State, Nigeria. Phone: +2348035170614,  
E-mail: olayanju@abuad.edu.ng © Copyright AJMS
Olayanju, et al.: Immunosupressive acidic protein is elevated in HIV Infection
Asian Journal of Medical Sciences | Sep-Oct 2017 | Vol 8 | Issue 5 9
common cause of  morbidity and mortality in HIV patients 
and are generally marked with cytopenia such as anaemia, 
neutropenia, lymphopenia and thrombocytopenia.3,4
The incidence and severity of  the cytopenia generally 
correlate to the stage of  the disease with anaemia being the 
most commonly encountered haematologic abnormality and 
a significant predictor of  progression to AIDS or death.5
The progression of  the HIV infection may be measured 
through various outcome measures with measurement of  
CD4 count as a gold standard.6 Obtaining CD4 counts 
requires the use of  expensive equipment, which are not 
readily available in resource-limited settings in Nigeria. The 
identification of  a surrogate laboratory tests that can help the 
clinician to predict progression as well as CD4 cell count does 
is useful not only to monitor the patients’ disease evolution 
but also to define the appropriate time to initiate treatment.7,8
Immunosupressive Acidic Protein (IAP) is an acute-phase 
reactant which has a close correlation with the impairment 
of  the hosts immunity. It has been found to suppress both 
phytohemagglutinin-induced lymphocyte blast formation 
and mixed lymphocyte reaction in vitro.9 It is a glycoprotein 
containing 31.5% Carbohydrates with a molecular weight 
of  50,000 and a single iso-electric point of  3.0. Impairment 
of  host immunity has been reported in a variety of  cancer 
patients, especially in advanced stage of  the disease and it 
has been demonstrated that IAP is the main component 
of  α-AG which causes these Impairment of  host immunity 
seen in different cancers.10
IAP is synthesized in the liver and has a serum concentration 
that increases in response to tissue injury, inflammation 
or infection. An increase in its concentration has been 
implicated in the immunosuppresion in tumor bearing 
animals and humans although the mechanism by which these 
occurs is not clearly stated.11, 12 Due to the inflammation or 
infection in HIV infection, It is highly plausible that there is 
correlation between IAP levels Immuno-haematopathology 
occurring in HIV infection. Based on the fact that IAP levels 
are easily estimated in human serum with a cost effective 
procedure using ELISA, there is the need to investigate if  
such relationship exists as this will provide a surrogate to 
the use of  the more expensive CD4 count as a marker for 
the disease progression.13
MATERIALS AND METHODS
Study area
This was a cross sectional study conducted at the HIV care 
and support center of  the Federal Teaching Hospital, Ido 
in Ekiti State which caters for Ido and the surrounding 
Towns like Ifaki, Otun, Aiyee in Ekiti-State.
Subjects
A total of  105 randomly selected participants who met 
the inclusion criteria of  the study were enrolled for this 
study. Eighty-five of  the participants were HIV positive 
individuals of  the HIV care and support center of  the 
Federal Teaching Hospital, Ido and 20 were HIV negative 
control subjects.
Sample size determination
A minimum sample size that is representative of  the study 
population was determined using a standardized method:
r+1 SD² (Z + Z)² r d²
SD is taken to be 0.8 from previous study14
r is ratio of  control to cases (1:5) = 0.2,
Z is standard normal variate for power 80% = 0.84,
Z is standard normal variate for 0.05% tolerable error = 
1.96,
d is the expected mean difference between case and control 
taken as 600 cell/µl.
0.2 + 10.82(0.84 +1.96)2
0.2 6002
=105 total participants
(For every 5 HIV infected subjects there is 1 control 
subject)
The sample size was calculated to be 105 having 85 test 
subjects and 20 control individuals.
Ethical approval
In line with Helsinki Declaration, approval for this 
study was obtained from the Health Research Ethics 
Committee of  the Federal Teaching Hospital., IdoEkiti, 
Ekiti State.
Inclusion criteria
1. May or may not be undergoing Anti Retroviral therapy.
2. Subjects should be at varying stages of  disease 
progression.
3. Should give his or her informed consent on the 
research study.
4. Subjects that are not HIV positive
Exclusion criteria
1. Subjects that are not HIV positive except control 
participants.
2. Subjects who do not give their informed consent.
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Informed consent
The participants were informed on the objectives, benefits 
and procedure of  the study and they were assured of  
confidentiality, voluntariness and protection. A written 
Informed consent was obtained from each of  the 
participant before enrolment into the study. They were also 
made aware of  their option to withdraw from the study 
any time without losing any of  the benefits and healthcare 
given by the hospital. The investigation was carried out at 
no cost to the participants.
Research design
Venous blood was collected from them and analyzed for 
CD4 count, complete blood count and IAP concentration. 
Results obtained will be tabulated and analyzed using 
appropriate statistical tool.
Sample collection
5 milliliters (5 mls) of  venous blood was collected from 
the antecubital fossa using aseptic technique.
Sample analysis
Full blood count and CD4 count were estimated and plasma 
separated for IAP concentration estimation, samples were 
analyzed for Full Blood Count and CD4 count within 6 
hours of  collection using Sysmex KX-21N Haematology 
and SL Cyflow machine. IAP was determined using the 
Enzyme Linked Immunosorbent Assay (ELISA) machine.
Statistical analysis
All experimental results were first evaluated to establish 
the necessity for using parametric statistics. The data was 
then determined to have a normal distribution. Degree of  
correlation of  each parameter analyzed with IAP was then 
determined using Statistical Packages for Social Science 
(SPSS) version 28.
RESULTS
The results of  this study was presented using scatter plot 
graphs (Figures 1-9) showing correlation relationship 
between Immunosuppressive Acidic Protein (IAP) and 
other variables estimated in the study. IAP did not have 
any correlation with percentage Monocyte and percentage 
Basophil differential count. The (r) values each of  the 
ART, NART and control group in all nine parameter with 
correlation IAP levels in the study are also stated.IAP had 
negative correlation with CD4 count, TWBC and the RBC 
dependent parameters.
DISCUSSION
The Human Immunodeficiency Virus (HIV) epidemic has 
spawned a scientific effort unprecedented in the history of  
infectious disease research.1 The need to find a surrogate 
to expensive CD4 cell count for laboratory monitoring 
and management of  HIV has been further emphasized 
by the reduction in support funds for the management of  
HIV infected people in resource poor settings in Africa.15 
This study was designed to assess the Haematological 
correlates of  Immunosupressive Acidic Protein marker 
(IAP) in HIV infection and the possibility of  using IAP as 
a surrogate marker for CD4 cell count in the monitoring 
of  immune status in HIV infected individuals. IAP is an 
acute-phase reactant and IAP is a glycoprotein containing 
31.5% carbohydrates with a molecular weight of  50,000 
and a single isoelectric point of  3.0. The presence of  an 
unusual amount of  immunosuppressive proteins in the 
serum of  cancer patients has been suggested as one of  
the factors which lead to depression of  host immunity.10
In this study, there was a negative correlation between 
the levels of  CD4, TWBC and IAP, in the ART, NART 
and in the control group as shown in Figure 1 and 
Figure 2, respectively. The result correlates with the 
findings in other immunosuppressive diseases as there is 
paucity of  information on IAP in relations to HIV. The 
immunosuppressive disease conditions include lung cancer 
as explained by study conducted elsewhere.10 A similar 
result was obtained in Primary cervical cancer patients16 and 
also in renal cancer.17,18 It is expected that there should be 
a relationship between the IAP levels in HIV infection and 
all these diseases as they are characterized by suppressed 
immune function, tissue injury, inflammation and infection 
as seen in HIV infection. IAP increases with reducing CD4 
count and TWBC (increasing disease severity) probably 
due to its increased synthesis in the liver in response to 
tissue injury, inflammation or infection which is typical of  
immunosuppressive states and advancing HIV infection.11
This study also found a positive correlation in the ART 
group between red blood cell, packed cell volume, 
haemoglobin and percentage eosinophil with the levels of  
IAP as shown in Figure 3, Figure 4, Figure 5 and Figure 9, 
respectively. This finding was inconsistent with those from 
similar studies.3,19 The inconsistency in the ART group with 
the previous study is possibly due to a better adherence to 
the treatment regimen by the patients involved in our study. 
However, there was a negative correlation in the NART 
group. This is in agreement earlier reported studies3,20 
possibly due to the absence of  therapy and thus a full effect 
of  HIV infection on haematopoiesis as seen in anaemia 
of  chronic disease affecting the kidney’s production of  
erythropoietin. The control group also showed a negative 
correlation which is in agreement with earlier conducted 
studies.3,19 This is due to the fact that IAP synthesis in the 
liver increases in response to tissue injury, infection or 
inflammation which are not observed in HIV infection 
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Figure 1: Scatter Plot showing relationship between IAP and CD4+ cell count in (a) ART (b) NART and (c) control group. (a) There is a negative 
correlation between the levels of IAP and CD4 in this group (r= -0.6).  (b) There is a very strong negative correlation between the levels of IAP 
and CD4 in this group (r= -0.9), (c) There is a very weak negative correlation between the levels of IAP and CD4 in this group (r= -0.2)
KEY
•  ART - HIV subjects on Anti Retroviral therapy
•  NART – HIV subjects not on Anti Retroviral therapy
•  IAP – Immunosuppresive Acidic Protein 
c
ba
Figure 2: Scatter Plot showing relationship between IAP and TWBC count in (a) ART (b) NART and (c) control group, (a) There is a negative 
correlation between the levels of IAP and TWBC in this group (r= -0.7). (b)  There is negative correlation between the levels of IAP and TWBC 
in this group (r= -0.5). (c)There is negative correlation between the levels of IAP and TWBC in this group (r= -0.3)
KEY
•  TWBC – Total White Blood Cell
c
ba
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or immunosuppressive conditions alone but also in some 
parasitic or inflammatory conditions which may happen 
to cause premature destruction of  red blood cells as seen 
in Malaria parasite infection or increased turnover of  
eosinophil.
This study also found that reticulocyte count had a negative 
correlation in the ART group and NART with the levels 
of  IAP and a positive correlation in the control group as 
seen in Figure 6. This is in good agreement with earlier 
studies21,22 possibly because of  the anaemia of  chronic 
Figure 4: Scatter Plot showing relationship between IAP and PCV in (a) ART (b) NART and (c) control group. (a) There is a very weak positive 
correlation between the levels of IAP and PCV in this group (r= 0.09). (b) There is a negative correlation between the levels of IAP and PCV in 
this group (r= -0.5). (c) There is a negative correlation between the levels of IAP and PCV in this group (r= -0.2) 
KEY
•  PCV – Packed Cell Volume
c
ba
Figure 3: Scatter Plot showing relationship between IAP and RBC count in (a) ART (b) NART and (c) control group, (a) There is a very weak 
positive correlation between the levels of IAP and RBC in this group (r= 0.01). (b) There is a negative correlation between the levels of IAP and 
RBC in this group (r= -0.6). (c) There is a negative correlation between the levels of IAP and RBC in this group (r= -0.3)
KEY
•  RBC – Red Blood Cell 
c
ba
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infection seen in advancing HIV infection (increasing IAP 
concentration) causing ineffective erythropiesis. There is 
also the decreased responsiveness to erythropoietin, blunted 
erythropoietin production in response to renal damage 
leading to reduction in reticulocyte count. The control 
group on the other hand has increasing reticulocyte count 
with increasing IAP due to the absence of  HIV infection 
and thus a fully functional erythropoietic mechanism to 
replenish old or destroyed red blood cells.23
Furthermore, there was a positive correlation in ART, NART 
and control groups between percentage neutrophil and IAP 
Figure 5:  Scatter Plot showing relationship between IAP and Haemoglobin Concentration in (a) ART (b) NART and (c) control group, (a) There 
is a Positive correlation between the levels of IAP and HB in this group (r= 0.2). (b) There is a Negative correlation between the levels of IAP and 
HB in this group (r= -0.5). (c) There is a Negative correlation between the levels of IAP and HB in this group (r= -0.2)
c
ba
Figure 6: Scatter Plot showing relationship between IAP and Reticulocyte Count in (a) ART (b) NART and (c) control group, a) There is a Negative 
correlation between the levels of IAP and Reticulocyte count in this group (r= -0.3). b) There is a Negative correlation between the levels of IAP and 
Reticulocyte count in this group (r= - 0.3). c) There is a Positive correlation between the levels of IAP and Reticulocyte count in this group (r= 0.2) 
c
ba
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concentration as seen in Figure 7. The findings in ART and 
NART was inconsistent while that of  the control group 
was consistent with that of  previous studies24,25 possibly 
due to undetected asymptomatic opportunistic bacterial 
infections which causes neutrophilia which might be present 
in participants in this study without showing off  symptoms.
Figure 8: Scatter Plot showing relationship between IAP and percentage Lymphocyte in (a) ART, (b) NART and (c) control group, (a) There is 
a Negative correlation between the levels of IAP and Lymphocyte in this group (r= -0.3), (b) There is a weak Negative correlation between the 
levels of IAP and Lymphocyte in this group (r= -0.02), (c) There is a weak Positive correlation between the levels of IAP and Lymphocyte in this 
group (r= 0.05)
c
ba
Figure 7: Scatter Plot showing relationship between IAP and percentage Neutrophil in (a) ART (b) NART and (c) control group, (a) There is a 
Positive correlation between the levels of IAP and Neutrophil in this group (r= 0.2), (b) There is a Positive correlation between the levels of IAP 
and Neutrophil in this group (r= 0.3). (c) There is a Positive correlation between the levels of IAP and Neutrophil count in this group (r= 0.1).
c
ba
Olayanju, et al.: Immunosupressive acidic protein is elevated in HIV Infection
Asian Journal of Medical Sciences | Sep-Oct 2017 | Vol 8 | Issue 5 15
Percentage lymphocyte showed a negative correlation 
with the levels of  IAP in both ART and NART groups 
and a positive correlation in the control group as shown 
in Figure 8. This was consistent with the findings of  the 
earlier studies.22,25 There is reduced lymphocyte count due 
to the direct destruction of  CD4+ T-Lymphocyte which 
makes up about 60%-70% of  T- lymphocyte population 
by HIV viral particles.
It is essential to note that elevation in IAP is not specific 
for HIV infection as other disease conditions that cause 
any form of  infection, tissue injury or inflammation as 
seen in most viral, bacterial and parasitic infections will 
produce an elevated IAP. The CD4 count however is a 
more specific marker as HIV particles directly infects CD4 
T-cells causing eventual destruction of  the cell and thus 
general reduction in its count although some other disease 
conditions can also produce reduction in CD4 cell count 
as seen in Tuberculosis.
CONCLUSION
The finding of  this study indicates a strong negative 
relationship between IAP and other immunohaematological 
parameters for monitoring Immune status in HIV infection; 
however the information gotten is not sufficient to indicate 
IAP as a predictor of  immune status in HIV infection. 
More studies should be done to evaluate IAP concentration 
at different clinical stages of  HIV infection while classifying 
HIV infected individuals as short-term progressors, rapid 
progressors or long-term non-progressors to determine 
if  IAP can be an accurate predictor of  immune status in 
HIV infection.
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